Diet induced weight loss accelerates onset of negative alliesthesia in obese women by Frankham, Patrick et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Public Health
Open Access Research article
Diet induced weight loss accelerates onset of negative alliesthesia in 
obese women
Patrick Frankham†1,2, Caroline Gosselin† and Michel Cabanac*†1,2
Address: 1Département d'Anatomie et Physiologie, Faculté de Médecine, Université Laval, Québec, CA and 2Groupe Interdisciplinaire de Recherche 
en Obésité (GIRO), Université Laval, Québec, CA
Email: Patrick Frankham - p.franhkam@sympatico.ca; Caroline Gosselin - gosselin.cabanac@sympatico.ca; 
Michel Cabanac* - michel.cabanac@phs.ulaval.ca
* Corresponding author    †Equal contributors
Abstract
Background: The physiological and behavioral responses to hypocaloric diet are to increase
energy intake to defend a steady body weight. We utilized the method of "negative alliesthesia" for
measuring the hedonic reponse to sweet stimulus before (Initial session) and 3 months after
entering a weight loss program. The negative alliesthesia test is known by physiologists but few
clinical data exist. It is based on the observation that repeated pleasant gustatory stimuli turn into
unpleasantness in the process of alliesthesia. At first visit participants repeatedly ingested sweet
stimuli until they found them unpleasant and rated quantitatively on a linear analogue scale their
hedonic experience. This procedure was repeated every 3 min until participants felt displeasure to
end the session. The same protocol was followed after three months of following a weight loss diet.
Dieting energy intake was from 1400 – 2000 kcal/d for 8 wk. Energy composition was 50% carb:25%
prot: 25% lipid. After 8 wk caloric intake increased by 50 kcal/wk, to reach daily intake of 1800 –
2400 kcal/d. Energy composition was 50% carb:22% prot: 27% lipid. We report results on the effect
of slow weight loss on negative alliesthesia in ten obese female participants enrolled in a
commercial diet program based on Canada's Food Guide (Mincavi®).
Results: Results showed that diet lowered the mean BMI (Initial session 36.8 +/- 1.8 vs. 3 mo 34.9
+/- 1.8 kg/m2). At 3 mo the onset of negative alliesthesia, time to abandon experimental session,
was shortened (Initial session 33 vs. 3 mo 24 min). The same trend was observed in the time to
reach indifference (Initial session 21.9 +/- 3.8 vs. 3 mo 16.2 +/-2.4 min). There was no observed
difference in maximum (Initial session +79.5 +/- 11.7; 3 mo +94.5 +/- 9.9 mm) and minimum (Initial
session -90.0 +/- 14.4; 3 mo -106 +/- 11.1 mm) hedonic rating.
Conclusion: Earlier onset of negative alliesthesia, as seen in our participants, is not consistent with
previous hedonic studies that showed delayed or absent negative alliesthesia in participants when
below their initial body weight. Therefore, it is hypothesized that the accelerated onset of negative
alliesthesia observed in our obese participants after weight loss is suggestive of a lowered body
weight set-point. Factors inherent to the weight loss diet studied here, such as mild energetic
restriction, lowered palatability, and diet composition, may have played a role in this experimental
outcome.
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Background
Energy balance is dependent upon a constant equilibrium
between the energy intake and energy expenditure. The
former is controlled by "appetite" through an intermedi-
ate phase termed "satiation" and its termination via "sati-
ety" [1-4]. The role of satiety in controlling food intake
begins once food has interacted with the receptors on the
tongue and nose. The bolus of food follows the oropha-
ryngeal duct to the stomach and duodenum, onward to
the jejuno-ileum and colon to be expelled once digested.
Along the transit, satiety signals arise from visceral affer-
ent nerve fibers through the gastro-intestinal tract itself
and the blood. At every step there is a cascade of neuro-
modulators that are postulated to participate, in part or
entirely, in satiety (bombesin, CCK, PYY, ghrelin, leptin,
insulin, glucocorticoids) [5-9]. Maladjustment in any
component may favor increase daily intake and thus con-
tribute to an upward drift in body weight and eventually
obesity.
Some authors attribute the rising prevalence of obesity
[10-13] simply to ever increasing caloric intake [14] and
decreased physical activity while others have implicated
over- or under-responses of satiating hormones or malad-
justed satiety cues [15,16]. Regardless of the underlying
etiology of obesity, this pathology is further complicated
by such biobehavioral factors as dietary variety, portion
size, snacking, cafeteria foods, increased palatability, and
low cost of calorie dense foods [14].
In the 50's, Keys' experiment of semi starvation and
refeeding in healthy normal-weight men [17] has pro-
vided data supporting the existence of autoregulatory
feedback signals linking the state of depletion of fat stores
to compensatory mechanisms operating via both food
intake and regulatory thermogenesis [18-20]. In the fol-
lowing years, a number of authors have defended the
hypothesis that body weight is regulated and that there
exists a ponderostat [21-45]. According to that point of
view, the major signal responsible for the overall stability
of body weight is the set-point. That point of view entails
that obesity results from a rise in body weight set-point,
an analog signal that is the aim the system tends to
achieve. If this were not the case, all defense mechanisms
would operate to counter the rise of body weight.
Others have argued against the set-point theory and have
instead substituted the term settling point [46,47].
According Davis & Wirtshafter [46] the absence of a set-
point would then mean the absence of regulation per se.
The same point of view against a set-point also existed in
temperature regulation. For Webb [48,49] the system
defends heat rather than temperature. Such a concept of
regulatory biological systems is actually equal to an
absence of any regulation and systems operating as simple
steady states. With temperature as well as with body
weight, the fact that responses (shivering, sweating, alli-
esthesia, thermogenesis, hoarding etc.) oppose changes to
temperature and to body weight minimize the signifi-
cance of the settling point hypothesis.
In previous studies, our laboratory has found that nega-
tive alliesthesia occurred when normal weight subjects
were maintained on a ad libitum bland monotonous diet
[50]. These subjects also experienced significant weight
loss. In addition, when maintained on a bland diet nor-
mal weight subjects' lose weight without reporting a sen-
sation of chronic hunger, a pattern understood as a
lowering of the body weight set-point [50]. Inversely,
when obese subjects lower their body weight while main-
tained on a caloric restriction diet it has been shown that
satiety was decreased or suppressed [51]. The only differ-
ence between normal and obese patients is that the
response takes place at a higher body weight in the latter
[51].
The gustatory pleasure evoked by a sweet stimulus in sub-
jects maintained under varying weight conditions reveals
valuable information about the internal state of the bio-
logical system [32,51-53]. The decrease of initial pleasure
after repeated ingestion of a sweet stimulus demonstrates
an important physiological mechanism termed "negative
alliesthesia".
The relationship between obese individuals' alliesthesia
and their body weight has scarcely been studied in the
clinical setting. The aim of the present clinical study was
to compare the onset of negative alliesthesia in obese sub-
jects before- and three months after following a weight
loss diet.
Methods
Study participants
Ten female participants from the greater Quebec City
Region were recruited from the Minçavi weight loss pro-
gram. All participants were at least 18 yr of age and had
stable body weight at the time of joining the program. Sta-
ble body weight was defined as not having gained or lost
more than 2 kg in the past month. Patient demographics
are outlined in Table 1. The protocols were described in
detail to the participants, without any use of the word set-
point, and without mentioning the aim of the study.
Participants were instructed to fast overnight and arrive at
our laboratory early the following morning. At each visit,
only one participant was taken at a time. Participants
completed a general health questionnaire and body
weights were recorded before initiating the experimental
sessions.BMC Public Health 2005, 5:112 http://www.biomedcentral.com/1471-2458/5/112
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Inclusion and exclusion criteria
Diabetics (Type I and II) were excluded from participating
in the study. Smokers were also excluded because previ-
ous experimental results with the same hedonic method
used here have shown that transient nicotine can lower
the set-point for body weight [54], a result that was con-
firmed in rats [15].
Ethics, informed consent and compensation
The study protocol was approved by University Ethics
Committee and each participant signed an informed con-
sent before study initiation. Participants received forty
dollars per visit as a compensation for their participation
in the study. The monetary amount given is believed not
to have influenced participant's ratings.
Minçavi® commercial weight loss program
Minçavi® (phonetically: "thin for life" in French), is a com-
mercial weight loss program, based on Canada's Food
Guide recommendations. Upon joining the program, par-
ticipants, mostly women, receive a recipe book and are
explained the importance of eating 3 meals/day and
choosing foods from the four major food groups (grain
products, fruits/vegetables, milk/dairy products, meat/
meat alternate). The proposed recipes are based on inex-
pensive, readily available whole grain products, vegeta-
bles, fruits, lean meats, and low-fat dairy products. Group
leaders teach participants how to prepare a variety of
nutritious, well balanced and easy to cook meals. Group
leaders are people who have lost excess body weight and
have been maintaining a healthy body weight for at least
two years by following the very program they promote.
Participants are free to decide for themselves how much
weight they want to lose. However, the group leaders
establish the milestones in accordance to a recommended
5% loss in body weight.
Depending on their BMI, sex, age and physical activity,
participants are assigned one of the four diet plans that
range from 1400 to 2000 kcal/d (5852 to 8360 kJ/d) in
the weight loss phase. During that phase, it is estimated
that 50% of the energy is derived from carbohydrates,
25% from protein, and 25% from lipids. When partici-
pants reach the goal weight, they enter the "weight main-
tenance phase" and are taught to increase their caloric
intake by 50 kcal /wk, in a minimum of 8 wk, to eventu-
ally reach a daily intake of 1800 to 2400 kcal/d (7524 to
10 032 kJ/day) depending on energy needs. During this
second phase, diet composition changes slightly, with a
decrease in protein and an increase in lipid content (car-
bohydrates = 50%, protein = 22%, lipids = 27%).
In groups of 50 to 100, participants are instructed on how
to record everything they consume in a daily journal
designed for that purpose and they are invited to share
them with their group leader every week. Weigh-in ses-
sions followed by a 30 to 45 min lecture on various topics
(e.g., weight loss, nutrition, motivation) and recipe sam-
pling; take place on a weekly basis. In addition, the com-
mercial program provides support from a dietician
through telephone line and Internet.
Sweet stimuli
At first visit, participants were allowed to choose between
one of two sweet stimuli that would be presented to them
over the experiment. Participants were explained that the
stimuli would be ingested repeatedly over the session and
retained for the next visit. Stimuli were either Cantin® car-
amels (7-g) to be chewed or Ensure® Vanilla (7-ml) to be
drunk. Two different stimuli were offered, without being
tasted, to offer an alternative to those participants who
Table 1: Participant's demographics and descriptive data 
analyses. Obesity Class I, II & III according to World Health 
Organization Classification (World Health Organization, 
Geneva, 1998). Where Class I = BMI 30.0 to 34.9, Class II = BMI 
35.0 to 39.9 and Class III BMI > 40.0. At first visit participants 
chose either Cantin® caramel candy 7-g or Ensure® Vanilla 7-ml 
as stimulus for determination of hedonic rating. The stimulus 
was retained for following visits. At first visit (Initial session) 
participants were asked to subjectively indicate the age at which 
they considered themselves to have become obese. Our study 
participants were all female, the age at perceived onset of 
obesity correlated with first childbearing in all participants.
Participants Mean (± S.E.) Demographics
Sex (n)
Female 10
Age 31.5 ± 3.2
Body Mass Index †
Initial BMI 36.8 ± 1,8
3-Month Diet BMI 34.9 ± 1,8
Loss (%) 5.2 ± 0.2
Initial Body Weight (kg) 94.7 ± 3.0
3-Month Body Weight (kg) 89.9 ± 3.0
Loss (%) 5.2 ± 0.2
Obesity Class (BMI)
I (30.0 to 34.9) 3
II (35.0 to 39.9) 4
III (>40.0) 3
Stimulus chosen
Liquid (Ensure® liquid diet) 3
Solid (Cantin® caramel candy) 7
Age of Perceived Onset of Important Body Weight ‡ 24 ± 2 yr
†: The body mass index is the weight in kilograms divided by the 
square of the height in meters (kg/m2).
‡: This variable is defined as that time when participants were aware 
that they were "heavier" than "average" individuals. This response was 
correlated with childbearing in all participants.BMC Public Health 2005, 5:112 http://www.biomedcentral.com/1471-2458/5/112
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might not like caramel, or would be unable to chew due
to dental prosthesis.
Hedonic ratings
Participants ingested one sweet stimulus, and after 15 s
were asked to report their hedonic rating on a linear ana-
logue scale. The entire stimulus was masticated (caramel)
and swallowed, or drunk (Ensure®). Participants did not
rinse after ingesting the stimuli. This procedure was
repeated every 3 min until participants felt displeasure
and decided to end the experimental session. Participants
were instructed that they would have to decide by them-
selves when they chose to end the session out of displeas-
ure (disgust for the stimulus: negative alliesthesia).
Participants were instructed to indicate with a felt pen on
a washable board the hedonicity aroused by the stimulus.
They were to use an analogue scale with (0) in the middle
for an indifferent sensation, a positive (+) for a pleasant
sensation, and (-) for a displeasurable sensation. The dis-
tance (mm) from zero (0) would indicate the intensity of
pleasure or displeasure. After the participant wrote her
mark on the scale, the distance from zero (indifference)
was measured, then the mark was erased. The repeated rat-
ings were then plotted against time. Subjects performed
the first alliesthesia test before starting the diet and the
second one, three months after entering the program,
while still on the weight loss diet.
Data analysis
The percent change in body weight at three months from
initial session was calculated after the second session. This
value was determined by dividing the difference in body
weight between experimental sessions by initial session
body weight. Value was expressed as a percent. Endpoints
measured at each session were:
i. Body Mass Index (BMI). Determined by dividing partic-
ipant's body weight (kg) / participant's height squared
(m2).
ii. Time to reach zero rating for the hedonicity of taste sen-
sation. This variable is defined as the time taken by partic-
ipant to reach indifference after ingesting sweet stimuli
every 3 min. This variable is interpreted as indicative of
satiation.
iii. Time to abandon experimental session. This variable is
interpreted as full satiety through negative alliesthesia
since the participant was free to withdraw whenever she
chose.
iv. Amplitude of hedonic rating. The highest (maximal)
hedonic rating was the most pleasurable rating reported
by participants after ingesting sweet stimulus. In opposi-
tion, the lowest (minimal) hedonic rating was the most
displeasurable rating reported by participants after ingest-
ing a sweet stimulus.
v. To compare rate of alliesthesia, the Kaplan Meier's
method was used as for survival rate.
Results
After following the Minçavi® weight loss program for three
months, mean group body weight was significantly lower
(Initial session 94.7 +/- 3.0; 3 mo 89.9 +/- 3.0 kg; Stu-
dent's paired t = 9.90; p < 0.0001; two tailed; Table 1).
Maximal weight loss observed in our participants was 6.8
kg and minimal was 0.9 kg (Figure 1). Expressed as BMI,
the weight loss program caused a significant decrease after
three months (Initial session 36.8 +/- 1.8; 3 mo 34.9 +/-
1.8 kg/m2; Student's paired t  = 10.4; p < 0.0001; two
tailed). Body weight loss at 3 mo was 5.2 % ± 0.2 (Table 1)
When patients repeatedly ingested sweet stimuli and
reported their hedonic rating, the entire cohort of fasted
participants started with reports of pleasurable sensation
Individual body weight loss in 10 obese participants at Initial  session and 3 mo following a commercial regimen (Minçavi®) Figure 1
Individual body weight loss in 10 obese participants at Initial 
session and 3 mo following a commercial regimen (Minçavi®). 
Mean group body weight loss showed a statistically significant 
decrease (Initial session 94.7 +/- 3.0; 3 mo 89.9 +/- 3.0 kg; 
Student's paired t = 9.90; p < 0.0001; two tailed). The range 
of body weight loss was from 0.9 kg to 6.8 kg for all partici-
pants who followed the Minçavi® diet for three months. One 
participant (ID. S-MAV-01) was invited to return for a follow-
up visit after 6 mo on diet. Her body weight showed a con-
tinued decrease of 0.9 kg at 3 mo and 8.6 kg at 6 mo.BMC Public Health 2005, 5:112 http://www.biomedcentral.com/1471-2458/5/112
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and gave positive hedonic rating. Over the course of the
session the positive rating fell to zero or became negative,
indicating negative alliesthesia. A representative alliesthe-
sia kinetic from one participant before and while on the
Minçavi® diet is shown in Figure 2. The mean time to reach
zero rating, or indifference, revealed a statistically signifi-
cant earlier delay after dieting (Initial session 21.9 +/- 3.8;
3 mo 16.2 +/- 2.4 min; Student's paired t = 2.48; p =
0.0351; two tailed, Figure 3). The solid stimulus was cho-
sen by 7/10 of participants, over the liquid stimulus.
Regardless of the solid or liquid chosen, participants still
yielded identical kinetic profiles for alliesthesia before
and after weight loss.
In order to follow the time course of alliesthesia in our
experimental groups, we created survival curve using the
product limit method of Kaplan-Meier. This procedure
would cancel the fact that not all participants followed the
same time course and stayed for some duration. No event
times thus were considered missing or censored. The
median time to achieve negative alliesthesia was signifi-
cantly increased after diet (Log-rank chi-square = 4.312, df
= 1, p = 0.0378; Figure 4). Diet lowered the median time
to achieve negative alliesthesia (Initial session 33 vs. 3 mo
24 min). There was no difference in maximal and mini-
mal median hedonic rating (maximal Initial session +79.5
+/- 11.7 mm; 3 mo +94.5 +/- 9.9 mm; Wilcoxon = 14.5; p
= 0.1934 or minimal Initial session -90.0 +/- 14.4 mm; 3
mo -106 +/- 11.1 mm Wilcoxon = 22.0; p = 0.6250). The
absence of detecting a significant difference in this end-
point reveals that participant's hedonic rating for sweet
stimulus was unchanged after diet.
Discussion
Obese participants enrolled in the present study all lost
weight by following the Minçavi® weight loss program.
Although the overall group weight loss was statistically
significant, the clinical relevance of such a loss for any
individual participant (range 0.9 – 6.8 kg) cannot be
ascertained. However, for obese people even moderate
weight loss is thought to be beneficial if not physiologi-
cally at least psychologically[55,56]. All but one partici-
pant met the objective of a 5% decrease in BMI purported
by the Minçavi® program (Figure 1).
Historical data from a controlled clinical trial in morbidly
obese participants awaiting bariatric surgery and weight-
matched un-operated controls utilizing the same experi-
mental approach over a longer period revealed a similar
alliesthesia kinetic [57]. Curve parameters from the
present diet study suggest that negative alliesthesia as seen
A representative satiation kinetic from one obese participant  (Class I) at Initial session and 3 mo following a commercial  regimen (Minçavi®) Figure 2
A representative satiation kinetic from one obese participant 
(Class I) at Initial session and 3 mo following a commercial 
regimen (Minçavi®). The curve shows that time to reach zero 
rating significantly decreased from 21 min at Initial session to 
12 min at 3 mo on diet. The figure also shows that the over-
all time to abandon the experimental session, negative alli-
esthesia, was significantly decreased from 36 min at Initial 
session to 21 min at 3 mo on diet. From this satiation kinetic, 
the initial rating of pleasure (Initial session 125 mm) remained 
the same (3 mo 127 mm). The amplitude of rating (minimal 
and maximal hedonicity) was also similar from Initial session 
to 3 mo.
Mean (+/- SE) time to reach zero rating or indifference Figure 3
Mean (+/- SE) time to reach zero rating or indifference. The 
overall time to reach zero rating was significantly decreased 
after dieting (Initial session 21.9 +/- 3.8; 3 mo 16.2 +/- 2.4 
min; Student's paired t = 2.48; p = 0.0351; two tailed).BMC Public Health 2005, 5:112 http://www.biomedcentral.com/1471-2458/5/112
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in our participants is comparable to those reported in
morbidly obese patients (Historical controls initial ses-
sion: 25.5 min, vs. Historical controls 3 month: 30 min).
The pleasure aroused by sweet stimuli faded earlier at the
three month mark than at the initial session. The relation-
ship of pleasure with intake is obvious as a stimulus that
turns toward unpleasantness should be rejected; such neg-
ative alliesthesia is suggestive of a satiation process. Earlier
onset of negative alliesthesia was observed in each partic-
ipant who had lost weight. A weak negative correlation
was observed when we tested the relationship between
amount of weight loss from diet to time to achieve nega-
tive alliesthesia (Pearson r = -0.53). Correlation data did
however suggest the use of greater patients in future
studies utilizing the method. At first visit, all participants
yielded a response kinetic, that could be interpreted as
three distinct phases, namely; appetite, satiation, and sati-
ety. Because participants all arrived at our laboratory after
an overnight fast, their initial rating of hedonicity was
positive at every session. Each participant transitioned
through to what could be referred to as a "satiation
phase", indicative of a zero or indifferent hedonicity rat-
ing. The final phase, suggestive of satiety, was the aban-
donment due to significant displeasure and disgust for the
sweet stimulus. Thus, our obese participants displayed a
negative alliesthesia pattern similar to that observed in
normal weight subjects. It is likely that changes in alli-
esthesia observed here were linked to that specific diet and
that upon returning to their previous dietary habits, sub-
jects would probably return to their baseline response.
Previous experiments have focused mainly on shift in
taste preferences in obese and lean individuals after diet-
ing [53,58]. These investigations yielded equivocal results,
and assessed the changes in taste correlated with lowered
body weight. Our participants did not modify their initial
ratings although their weights were lowered from dieting.
Such a result would not support a changed taste prefer-
ence related to body weight in fasted subjects. Cummings,
Weigle, Frayo, Breen, Ma, Dellinger, & Purnell, [59] stud-
ied the effects of diet-induced weight loss on plasma ghre-
lin levels. Their subjects showed a significant 17%
decrease in BMI after six months. Although the popula-
tion studied was similar to ours, their experimental
approach to weight loss was more drastic than the
Minçavi® diet. Subjects from the Cummings study were
initially on a three-month liquid diet (1000 kcal/d) and
transitioned to a solid diet for the remainder of the study.
Conclusion
An earlier onset of negative alliesthesia was obvious at
three months when participants had lost weight and were
still on the Minçavi® diet. In the light of previous work in
animals and in humans cited earlier, these findings could
Kaplan-Meier curve was created to determine the time to  achieve an event: satiety Figure 4
Kaplan-Meier curve was created to determine the time to 
achieve an event: satiety. Diet showed a significant increase 
in the satiety rate at 3 mo vs. Initial session (Log-rank chi-
square = 4.312, df = 1, p = 0.0378). The median time to 
achieve satiety was lower after diet (24 min vs. 33 min).
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A Kaplan-Meier curve was created using historical control  data obtained from morbidly obese patients (BMI > 50)  awaiting bariatric surgery Figure 5
A Kaplan-Meier curve was created using historical control 
data obtained from morbidly obese patients (BMI > 50) 
awaiting bariatric surgery. Subjects did not receive any diet 
intervention. Participants all received the same test for nega-
tive alliesthesia described in the methods section. Both 
groups showed a similar satiety kinetic for sweet stimulus 
(Log-rank chi-square = 0.045, df = 1, p = 0.8311, NS). The 
median time to achieve satiety in both groups were compara-
ble (Initial session 25.5 min vs. 3 month 30 min). These 
results suggest the test is reproducible in a clinical setting for 
patients.
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be interpreted has a lowering of body weight set-point.
Dietary factors may have played a role in this phenome-
non. Since Minçavi® promotes a diet that is lower in fat
and in added sugar, it is likely that the participants have
found it to be less palatable than their usual diet. Earlier
work has shown that a decrease in palatability could lower
one's body weight set-point [50]. Some studies also sug-
gest that diets that are relatively high in protein [60-62]
and that have a low glycemic index [63-67] such as the
Minçavi® diet, may promote satiety and weight loss. It is
possible such factors, when present in the diet, contribute
to lower one's set-point.
Maintaining a lowered set-point, by consuming a sensible
diet that promotes satiety and gradual weight loss, may be
the key for long-term success, as the body strives to main-
tain a body weight close to that set-point by reducing food
intake and enhancing energy expenditure. Further studies
are needed to better understand alliesthesia in obese indi-
viduals and its link to body weight set-point.
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